Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | %Female (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71 | Current Treatment Options in Oncology | journal | 0.101 Q4 | 66 | 53 | 52 | 1912 | 2 | 52 | 0.04 | 36.08 | 20.39 | |
70 | Annals of Cancer Research and Therapy | journal | 0.104 Q4 | 7 | 0 | 28 | 0 | 1 | 28 | 0.00 | 0.00 | 0.00 | |
69 | Clinical Journal of Oncology Nursing | journal | 0.113 Q4 | 53 | 71 | 141 | 278 | 20 | 127 | 0.13 | 3.92 | 87.80 | |
68 | National Toxicology Program technical report series | journal | 0.121 | 22 | 7 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
67 | Advances in Oncobiology | book series | 0.124 Q4 | 3 | 0 | 23 | 0 | 2 | 20 | 0.09 | 0.00 | 0.00 | |
66 | Cancer Case Presentations: The Tumor Board | journal | 0.128 Q4 | 2 | 0 | 32 | 0 | 1 | 14 | 0.00 | 0.00 | 0.00 | |
65 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.162 Q3 | 65 | 46 | 32 | 1290 | 14 | 31 | 0.44 | 28.04 | 27.72 | |
64 | Clinical Lung Cancer | journal | 0.165 Q3 | 74 | 54 | 39 | 1472 | 8 | 29 | 0.21 | 27.26 | 29.03 | |
63 | Clinical Breast Cancer | journal | 0.179 Q3 | 80 | 49 | 38 | 1460 | 11 | 36 | 0.29 | 29.80 | 33.65 | |
62 | Current Problems in Cancer | journal | 0.188 Q3 | 47 | 11 | 41 | 1447 | 21 | 35 | 0.36 | 131.55 | 25.00 | |
61 | Current Oncology Reports | journal | 0.201 Q3 | 77 | 75 | 112 | 2654 | 44 | 110 | 0.39 | 35.39 | 17.59 | |
60 | Sarcoma | journal | 0.217 Q3 | 53 | 19 | 82 | 439 | 36 | 78 | 0.25 | 23.11 | 16.67 | |
59 | Breast | journal | 0.236 | 98 | 146 | 232 | 3523 | 119 | 212 | 0.39 | 24.13 | 34.21 | |
58 | Cancer Control | journal | 0.259 Q3 | 80 | 91 | 235 | 2568 | 140 | 211 | 0.69 | 28.22 | 21.85 | |
57 | Cytotherapy | journal | 0.273 Q3 | 105 | 56 | 104 | 1610 | 70 | 91 | 0.67 | 28.75 | 34.67 | |
56 | Journal of Psychosocial Oncology | journal | 0.282 Q3 | 52 | 20 | 53 | 749 | 35 | 52 | 0.64 | 37.45 | 68.89 | |
55 | Urologic Oncology: Seminars and Original Investigations | journal | 0.302 Q3 | 85 | 84 | 195 | 3307 | 292 | 171 | 1.32 | 39.37 | 14.35 | |
54 | Journal of Cancer Education | journal | 0.331 Q3 | 52 | 57 | 162 | 742 | 108 | 142 | 0.58 | 13.02 | 59.29 | |
53 | Molecular Imaging and Biology | journal | 0.339 Q3 | 78 | 0 | 132 | 0 | 93 | 132 | 0.64 | 0.00 | 0.00 | |
52 | Medical Dosimetry | journal | 0.354 Q3 | 46 | 39 | 126 | 674 | 67 | 124 | 0.41 | 17.28 | 13.25 | |
51 | Oncology | journal | 0.376 Q3 | 83 | 259 | 916 | 2375 | 893 | 879 | 0.94 | 9.17 | 24.23 | |
50 | Pediatric Blood and Cancer | journal | 0.402 Q2 | 128 | 234 | 714 | 4323 | 681 | 627 | 0.93 | 18.47 | 35.76 | |
49 | Journal of Gastrointestinal Cancer | journal | 0.404 Q2 | 53 | 46 | 172 | 1284 | 243 | 161 | 1.29 | 27.91 | 17.89 | |
48 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.412 Q2 | 90 | 138 | 415 | 2943 | 528 | 404 | 1.21 | 21.33 | 21.99 | |
47 | Medical Oncology | journal | 0.432 Q2 | 90 | 38 | 159 | 949 | 232 | 154 | 1.43 | 24.97 | 34.08 | |
46 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.492 Q2 | 68 | 58 | 170 | 1918 | 256 | 152 | 1.53 | 33.07 | 27.49 | |
45 | Cancer Nursing | journal | 0.512 Q2 | 86 | 67 | 174 | 2154 | 229 | 173 | 0.98 | 32.15 | 70.87 | |
44 | Anti-Cancer Drugs | journal | 0.514 Q2 | 102 | 131 | 370 | 4095 | 644 | 369 | 1.65 | 31.26 | 21.81 | |
43 | Journal of Pediatric Hematology/Oncology | journal | 0.559 Q2 | 86 | 170 | 370 | 3185 | 445 | 287 | 1.00 | 18.74 | 37.82 | |
42 | European Journal of Cancer Prevention | journal | 0.647 Q2 | 88 | 90 | 253 | 2408 | 496 | 229 | 1.80 | 26.76 | 33.62 | |
41 | Cancer Investigation | journal | 0.666 Q2 | 93 | 100 | 296 | 5254 | 453 | 254 | 1.50 | 52.54 | 26.80 | |
40 | Radiation Oncology Investigations | journal | 0.671 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
39 | Oncology Research | journal | 0.682 Q2 | 76 | 33 | 346 | 1011 | 722 | 343 | 1.96 | 30.64 | 34.10 | |
38 | Recent Results in Cancer Research | book series | 0.682 Q2 | 63 | 25 | 213 | 270 | 368 | 213 | 1.94 | 10.80 | 26.60 | |
37 | Oncologist | journal | 0.713 Q2 | 189 | 113 | 226 | 3430 | 435 | 191 | 2.26 | 30.35 | 27.65 | |
36 | Drug Resistance Updates | journal | 0.727 Q2 | 132 | 42 | 155 | 3286 | 324 | 146 | 1.77 | 78.24 | 30.12 | |
35 | Journal of Surgical Oncology | journal | 0.764 Q2 | 131 | 206 | 720 | 6196 | 1364 | 649 | 1.62 | 30.08 | 16.28 | |
34 | Surgical Oncology Clinics of North America | journal | 0.765 Q2 | 68 | 66 | 185 | 3493 | 284 | 150 | 1.10 | 52.92 | 18.49 | |
33 | Blood Reviews | journal | 0.782 Q2 | 112 | 19 | 63 | 2034 | 193 | 63 | 3.00 | 107.05 | 30.00 | |
32 | Anti-Cancer Drug Design | journal | 0.795 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
31 | Cancer Science | journal | 0.834 Q1 | 166 | 183 | 588 | 5722 | 1261 | 581 | 2.10 | 31.27 | 13.61 | |
30 | Seminars in Surgical Oncology | journal | 0.836 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
29 | Hematology/Oncology Clinics of North America | journal | 0.858 Q1 | 95 | 64 | 238 | 5132 | 620 | 221 | 2.10 | 80.19 | 23.68 | |
28 | Melanoma Research | journal | 0.864 Q1 | 80 | 85 | 238 | 2390 | 480 | 225 | 1.90 | 28.12 | 32.43 | |
27 | Nutrition and Cancer | journal | 0.879 Q1 | 130 | 99 | 291 | 4035 | 777 | 286 | 2.49 | 40.76 | 38.60 | |
26 | Gynecologic Oncology | journal | 0.895 Q1 | 186 | 389 | 1017 | 8843 | 2416 | 908 | 2.30 | 22.73 | 30.70 | |
25 | Current Opinion in Oncology | journal | 1.076 Q1 | 104 | 102 | 333 | 4271 | 847 | 302 | 2.62 | 41.87 | 27.89 | |
24 | Cancer Surveys | journal | 1.117 Q1 | 43 | 0 | 38 | 0 | 87 | 33 | 0.00 | 0.00 | 0.00 | |
23 | Cancer journal (Sudbury, Mass.) | journal | 1.148 Q1 | 102 | 90 | 279 | 3702 | 615 | 211 | 1.94 | 41.13 | 26.09 | |
22 | Journal of the National Cancer Institute. Monographs | journal | 1.212 Q1 | 95 | 46 | 77 | 1192 | 279 | 73 | 3.16 | 25.91 | 32.14 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®